Boston Scientific (BSX) Q1 2025 Earnings
Boston Scientific reported Q1 2025 revenue of $4.7B (+20.9% YoY), beat analyst consensus of $4.6B by $91.3M. Diluted EPS came in at $0.75 (+33.9% YoY), beat the $0.67 consensus by $0.08. Boston Scientific reports across 2 business segments, led by Cardiovascular and MedSurg.
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Boston Scientific's Q1 2025 earnings report.
Boston Scientific (BSX) reported Q1 2025 earnings on April 23, 2025 before market open.
Boston Scientific reported revenue of $4.7B and diluted EPS of $0.75 for Q1 2025.
Revenue beat the consensus estimate of $4.6B by $91.3M. EPS beat the consensus estimate of $0.67 by $0.08.
Compared to the same quarter a year prior, revenue grew 20.9% from $3.9B a year earlier and diluted EPS grew 33.9% from $0.56.
You can read the 10-Q periodic report (0000885725-25-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.